text: Novartis: FDA Wants More Certican Details Swiss drug maker Novartis Pharma AG said Monday that the Food and Drug Administration has again requested more information on the company #39;s Certican treatment, when used in combination with Neoral, to prevent heart and kidney transplant rejection episodes 